后部 mitrale 叶片突起:一种罕见但可能的并发症 皮肤穿透的 mitrale 门手术
Francesca Napoli1, Ciro Vella1, Vittorio Romano1
1Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
概括
由于本地传单干扰,跨导管 mitra 入环 (MViR) 程序可能会失败. 这一案例凸显了多余的后部 mitrale 传单如何导致 MViR 后急性 mitrale 缺陷,这是一个很少被理解的并发症.
科学领域:
- 心脏病学 心脏病学
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
背景情况:
- mitra 回是通过修复或更换治疗的, annuloplasty 是一个关键的技术.
- 传导管中枢入环 (MViR) 是一种新兴的选择,用于高风险的患者,以修复失败.
- 越来越多地认识到MViR的并发症,特别是传单相互作用.
研究的目的:
- 调查本地 mitrale 传单在 MViR 后急性生物假体功能障碍中的作用.
- 为了突出后部 mitrale 传单在 MViR 并发症的低估的影响.
- 介绍一个临床案例,说明后部传单干扰假肢功能.
主要方法:
- 文献综述侧重于MViR并发症和本地传单相互作用.
- 一个接受MViR的患者的临床病例介绍.
- 对心声回声和手术数据的分析,以确定急性生物假体功能障碍的原因.
主要成果:
- 前额叶叶片并发症 (例如,外流通道阻塞) 已得到充分证实.
- 后部 mitrale 传单并发症是不太了解,经常被忽视.
- 在MViR病例中,存在冗余的后部 mitrale 叶片被确定为急性严重 mitrale 缺陷的原因.
结论:
- 在MViR手术中,原生 mitra 传单可以导致急性生物假体功能障碍.
- 在MViR并发症中,后额叶叶片在MViR并发症中的作用需要进一步研究.
- 仔细的程序前评估和程序内评估对于减轻与MViR的传单干扰相关的风险至关重要.
相关概念视频
01:27Mitral Valve Prolapse I: Introduction
4
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
4
01:20Mitral Regurgitation I: Introduction
4
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
01:22Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
01:22Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3
01:19Mitral Valve Prolapse III: Nursing Management
5
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
5
01:25Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4